Enorama Pharma AB (publ)

Enorama Pharma AB (publ) is a Swedish pharmaceutical enterprise primarily engaged in the creation, production, and distribution of specialized chewing gums. These products are formulated with established generic active ingredients. The company's offerings encompass nicotine chewing gum, designed to aid individuals in quitting smoking, as well as medical cannabis chewing gums. The cannabis-based gums are intended for a variety of applications, including non-pharmaceutical uses, along with therapeutic purposes such as targeted drug delivery through the oral lining and the treatment of allergic rhinitis. This firm operates out of its headquarters in Malmö, Sweden.